Free Trial

Eupraxia Pharmaceuticals (EPRX) News Today

Eupraxia Pharmaceuticals logo
$5.26 -0.13 (-2.32%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EPRX Latest News

Analysts Set Expectations for EPRX FY2025 Earnings
Cantor Fitzgerald Forecasts EPRX FY2025 Earnings
Eupraxia Pharma director buys as stock tests top of range
Eupraxia Pharmaceuticals Inc
Eupraxia Pharmaceuticals reports FY24 EPS (76c), consensus (63c)
Eupraxia Pharmaceuticals’ EP-104GI shows efficacy in esophagitis trial
Eupraxia Pharmaceuticals (EPRX) Receives a Buy from Craig-Hallum
Eupraxia Pharmaceuticals Taps Alex Rothwell as CFO
Eupraxia Pharmaceuticals Announces CFO Succession
Get Eupraxia Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPRX and its competitors with MarketBeat's FREE daily newsletter.

EPRX Media Mentions By Week

EPRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EPRX
News Sentiment

1.68

0.38

Average
Medical
News Sentiment

EPRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EPRX Articles
This Week

1

1

EPRX Articles
Average Week

Get Eupraxia Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EPRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:EPRX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners